OPKO HEALTH, INC.
Ownership & governance
Executives 5Directors 10Avg age 75Avg tenure 13.5y
PF
Phillip Frost
Chief Executive Officer
Age 88Since 2007-03-26Profile →
+14
Executives5
Board of directors10
PF
Phillip Frost→
Chairman
Age 88Since 2007-03-26
JP
John Paganelli→
Director/Board Member
Age 91Since 2003-11-30
SR
Steven Rubin→
Director/Board Member
Age 65Since 2007-01-31
JH
Jane Hsiao→
Director/Board Member
Age 78Since 2007-01-31
RP
Richard Pfenniger→
Director/Board Member
Age 70Since 2007-12-31
LY
Lin-Tsing Yu→
Director/Board Member
Age 82Since 2009-04-22
RM
Roger Medel→
Director/Board Member
Age 79Since 2020-12-17
PL
Prem Lachman→
Director/Board Member
Age 65Since 2021-02-28
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Phillip Frost | 33.51 % | 253,004,406 |
| Rubric Capital Management LP | 6.329 % | 47,791,243 |
| Elias Zerhouni | 5.389 % | 40,694,928 |
| BlackRock Advisors LLC | 4.481 % | 33,833,777 |
| Jane Hsiao | 4.387 % | 33,127,284 |
Catalog · 2026-07-09
Proxy officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Phillip Frost | Chairman | 2007-03-26 | - |
| Adam Logal | Director or executive officer | — | 2,004,162 |
| Alice Lin-Tsing Yu, M.D., Ph.D., Director | Director or executive officer | — | 266,490 |
| Elias Zerhouni | Director/Board Member | 2022-05-08 | - |
| Gary Nabel | Director/Board Member | 2022-05-08 | - |
| Jane Hsiao | Director/Board Member | 2007-01-31 | - |
| John A. Paganelli, Director | Director or executive officer | — | 593,515 |
| John Paganelli | Director/Board Member | 2003-11-30 | - |
Proxy · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Broker actions40 of 56
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Barrington Research | Downgrade | Market Perform | — | 2026-04-29 |
| Barrington Research | Maintained | Outperform | 1.5 | 2026-03-02 |
| JP Morgan | Initiated | Neutral | — | 2025-11-20 |
| Jefferies | Downgrade | Hold | 1.6 | 2025-10-31 |
| Barrington Research | Maintained | Outperform | 2.25 | 2025-10-30 |
| Barrington Research | Maintained | Outperform | 2.25 | 2025-05-01 |
| JP Morgan | Initiated | Neutral | — | 2025-04-25 |
| HC Wainwright & Co. | Reiterated | Buy | 3 | 2025-04-07 |
| HC Wainwright & Co. | Reiterated | Buy | 3 | 2025-03-19 |
| HC Wainwright & Co. | Reiterated | Buy | 3 | 2025-03-12 |
| Barrington Research | Maintained | Outperform | 2.25 | 2025-03-12 |
| HC Wainwright & Co. | Reiterated | Buy | 3 | 2025-03-03 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.